Evidence map›Paper›PMID 34208335›Full record

ArticlePathogens (Basel, Switzerland)2021

Regulation of hBD-2, hBD-3, hCAP18/LL37, and Proinflammatory Cytokine Secretion by Human Milk Oligosaccharides in an Organotypic Oral Mucosal Model.

Ulvi K Gürsoy, Krista Salli, Eva Söderling, Mervi Gürsoy, Johanna Hirvonen, Arthur C Ouwehand

Open access · goldAbstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ulvi K GürsoyDepartment of Periodontology, Institute of Dentistry, University of Turku, Lemminkäisenkatu, 2, 20520 Turku, Finland.ORCID 0000-0002-1225-5751
Krista SalliGlobal Health and Nutrition Science, IFF Health & Biosciences, Sokeritehtaantie, 20, 02460 Kantvik, Finland.ORCID 0000-0003-3304-3771
Eva SöderlingDepartment of Periodontology, Institute of Dentistry, University of Turku, Lemminkäisenkatu, 2, 20520 Turku, Finland.
Mervi GürsoyDepartment of Periodontology, Institute of Dentistry, University of Turku, Lemminkäisenkatu, 2, 20520 Turku, Finland.ORCID 0000-0001-8545-6821
Johanna HirvonenGlobal Health and Nutrition Science, IFF Health & Biosciences, Sokeritehtaantie, 20, 02460 Kantvik, Finland.
Arthur C OuwehandGlobal Health and Nutrition Science, IFF Health & Biosciences, Sokeritehtaantie, 20, 02460 Kantvik, Finland.ORCID 0000-0001-8348-0633
University of Turku · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human milk oligosaccharides (HMOs), the third largest solid fraction in human milk, can modulate inflammation through Toll-like receptor signaling, but little is known about their immunomodulatory potential in the oral cavity. In this study, we determined whether the HMOs 2'-fucosyllactose (2'-FL) and 3-fucosyllactose (3-FL) regulate human-beta defensin (hBD)-2 and -3, cathelicidin (hCAP18/LL-37), and cytokine responses in human gingival cells using a three-dimensional oral mucosal culture model. The model was incubated with 0.1% or 1% 2'-FL and 3-FL, alone and in combination, for 5 or 24 h, and hBD-2, hBD-3, and hCAP18/LL-37 were analyzed by immunohistochemistry. The expression profiles of interleukin (IL)-1, IL-1RA, IL-8, and monocyte chemoattractant protein (MCP)-1 were determined by LUMINEX immunoassay. The combination of 1% 2'-FL and 1% 3-FL, and 1% 3-FL alone, for 24 h upregulated hBD-2 protein expression significantly (

Indexed as

2′-fucosyllactose3-fucosyllactosecathelicidinhuman beta defensinsoral mucosal model

Identifiers

PMID34208335
PMCPMC8231254
OpenAlexW3171393639

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.